Technology
Health
Biotechnology

Autolus Therapeutics

$14.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.76 (-4.99%) Today
-$0.08 (-0.55%) As of 4:44 PM EDT after-hours

Why Robinhood?

You can buy or sell AUTL and other stocks, options, ETFs, and crypto commission-free!

About AUTL

Autolus Therapeutics plc American Depositary Share, also called Autolus Therapeutics, is a biopharmaceutical company. It engages in the development of cancer treatments. Read More The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom.

Employees
166
Headquarters
London, Greater London
Founded
2018
Market Cap
611.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
151.76K
High Today
$15.41
Low Today
$14.23
Open Price
$15.41
Volume
59.10K
52 Week High
$53.24
52 Week Low
$14.23

Collections

Technology
Health
Biotechnology
Cancer Prevention
Therapy
Biopharmaceutical
Pharmaceutical
2018 IPO

AUTL Earnings

-$0.69
-$0.63
-$0.58
-$0.52
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 14, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.